29
Active Trials
10
Phase 1
20
Phase 2
5
Phase 3
6
Therapeutic Areas
Immunology
10 active / 23 total
Oncology
4 active / 7 total
Respiratory
3 active / 8 total
Rare Disease
2 active / 2 total
Cardiovascular
2 active / 2 total
CNS
2 active / 2 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)